Cite
Clinical characteristics of patients who developed hepatocellular carcinoma after hepatitis C virus eradication with interferon therapy: current status in Japan.
MLA
Sato, Akira, et al. “Clinical Characteristics of Patients Who Developed Hepatocellular Carcinoma after Hepatitis C Virus Eradication with Interferon Therapy: Current Status in Japan.” Internal Medicine (Tokyo, Japan), vol. 52, no. 24, 2013, pp. 2701–06. EBSCOhost, https://doi.org/10.2169/internalmedicine.52.1180.
APA
Sato, A., Sata, M., Ikeda, K., Kumada, T., Izumi, N., Asahina, Y., Osaki, Y., Chayama, K., Kaneko, S., Sakai, A., Onji, M., Hiasa, Y., Omura, T., Ozeki, I., Yokosuka, O., Shiina, S., Itsubo, M., Nishiguchi, S., Hirano, K., … Ichida, T. (2013). Clinical characteristics of patients who developed hepatocellular carcinoma after hepatitis C virus eradication with interferon therapy: current status in Japan. Internal Medicine (Tokyo, Japan), 52(24), 2701–2706. https://doi.org/10.2169/internalmedicine.52.1180
Chicago
Sato, Akira, Michio Sata, Kenji Ikeda, Takashi Kumada, Namiki Izumi, Yasuhiro Asahina, Yukio Osaki, et al. 2013. “Clinical Characteristics of Patients Who Developed Hepatocellular Carcinoma after Hepatitis C Virus Eradication with Interferon Therapy: Current Status in Japan.” Internal Medicine (Tokyo, Japan) 52 (24): 2701–6. doi:10.2169/internalmedicine.52.1180.